This mechanism is illustrated in Figure 2, which summarizes the effects of DNMT1 inhibition by agents such as decitabine and azacitidine, including the reactivation of tumour suppressor genes and miRNA-mediated feedback. The gene discussed is DNMT1; the disease is neoplasm.